357 related articles for article (PubMed ID: 7627139)
1. Expression and purification of active form of HIV-1 protease from E.coli.
Wan M; Loh BN
Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
3. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.
Strickler JE; Gorniak J; Dayton B; Meek T; Moore M; Magaard V; Malinowski J; Debouck C
Proteins; 1989; 6(2):139-54. PubMed ID: 2695927
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
5. An E. coli expression system which detoxifies the HIV protease.
Korant BD; Rizzo CJ
Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
Tomasselli AG; Paddock DJ; Curry KA; Garlick RL; Leone JW; Lull JM; Mutchler VT; Baker CA; Cavey GS; Mathews WR; Shelly JA; Finzel BC; Baldwin ET; Wells PA; Tomich CS
Protein Expr Purif; 1998 Dec; 14(3):343-52. PubMed ID: 9882568
[TBL] [Abstract][Full Text] [Related]
7. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
[TBL] [Abstract][Full Text] [Related]
10. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.
Wondrak EM; Louis JM
Biochemistry; 1996 Oct; 35(39):12957-62. PubMed ID: 8841142
[TBL] [Abstract][Full Text] [Related]
11. Comparison of HIV-1 protease expression in different fusion forms.
Wan M; Takagi M; Loh BN; Imanaka T
Biochem Mol Biol Int; 1995 Jun; 36(2):411-9. PubMed ID: 7663445
[TBL] [Abstract][Full Text] [Related]
12. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human cytidine deaminase: expression, purification, and characterization.
Vincenzetti S; Cambi A; Neuhard J; Garattini E; Vita A
Protein Expr Purif; 1996 Sep; 8(2):247-53. PubMed ID: 8812871
[TBL] [Abstract][Full Text] [Related]
14. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
Menéndez-Arias L; Gotte D; Oroszlan S
Virology; 1993 Oct; 196(2):557-63. PubMed ID: 8372434
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
Towler EM; Gulnik SV; Bhat TN; Xie D; Gustschina E; Sumpter TR; Robertson N; Jones C; Sauter M; Mueller-Lantzsch N; Debouck C; Erickson JW
Biochemistry; 1998 Dec; 37(49):17137-44. PubMed ID: 9860826
[TBL] [Abstract][Full Text] [Related]
16. Optimizing HIV-1 protease production in Escherichia coli as fusion protein.
Volontè F; Piubelli L; Pollegioni L
Microb Cell Fact; 2011 Jun; 10():53. PubMed ID: 21718537
[TBL] [Abstract][Full Text] [Related]
17. An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies.
Nguyen HL; Nguyen TT; Vu QT; Le HT; Pham Y; Trinh PL; Bui TP; Phan TN
Protein Expr Purif; 2015 Dec; 116():59-65. PubMed ID: 26231073
[TBL] [Abstract][Full Text] [Related]
18. Cloning, high-yield expression in Escherichia coli, and purification of biologically active HIV-1 Tat protein.
Kirsch T; Boehm M; Schuckert O; Metzger AU; Willbold D; Frank RW; Rösch P
Protein Expr Purif; 1996 Aug; 8(1):75-84. PubMed ID: 8812837
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease.
Hutoran M; Britan E; Baraz L; Blumenzweig I; Steinitz M; Kotler M
Virology; 2004 Dec; 330(1):261-70. PubMed ID: 15527851
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.
Cheynet V; Verrier B; Mallet F
Protein Expr Purif; 1993 Oct; 4(5):367-72. PubMed ID: 8251747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
